drugset / Trial / NCT07361354
An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants
Timeline
- Start
- 2026-01-05
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGA2118 | Unknown | — | Subcutaneous |
Indications
No indication recorded.